We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$49.3M
AUM Growth
+$27.8M
Cap. Flow
+$1.13B
Cap. Flow %
2,299.05%
Top 10 Hldgs %
79.1%
Holding
195
New
101
Increased
30
Reduced
3
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 33.04%
2 Financials 26.97%
3 Healthcare 15.29%
4 Industrials 4.49%
5 Communication Services 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTM
76
DELISTED
Tata Motors Limited
TTM
$21K 0.04%
+717
New +$18.1K
GSK icon
77
GSK
GSK
$104B
$20K 0.04%
+392
New +$19.5K
CRDC
78
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$20K 0.04%
5,646
-1
-0% -$3
DJP icon
79
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$800M
$18K 0.04%
+815
New +$17K
KMI icon
80
Kinder Morgan
KMI
$71.7B
$18K 0.04%
1,000
PRKS icon
81
United Parks & Resorts
PRKS
$2.1B
$17K 0.03%
820
+213
+35% +$3.98K
SDRL
82
DELISTED
Seadrill Limited Common Stock
SDRL
$17K 0.03%
19
ETSY icon
83
Etsy
ETSY
$7.75B
$16K 0.03%
1,786
+900
+102% +$7.2K
SLV icon
84
iShares Silver Trust
SLV
$28B
$16K 0.03%
+1,071
New +$15.2K
PXH icon
85
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.94B
$15K 0.03%
962
+1
+0.1% +$14
TNK icon
86
Teekay Tankers
TNK
$2.75B
$15K 0.03%
+510
New +$17.6K
WFC icon
87
Wells Fargo
WFC
$261B
$15K 0.03%
+317
New +$15.5K
KITE
88
DELISTED
Kite Pharma, Inc.
KITE
$15K 0.03%
+322
New +$15.6K
OPWR
89
DELISTED
OPOWER INC COM STK (DE)
OPWR
$14K 0.03%
+2,031
New +$16.2K
CRM icon
90
Salesforce
CRM
$151B
$13K 0.03%
181
ERX icon
91
Direxion Daily Energy Bull 2X ETF
ERX
$238M
$13K 0.03%
+55
New +$10.9K
IWM icon
92
iShares Russell 2000 ETF
IWM
$79.8B
$13K 0.03%
+120
New +$12.4K
C icon
93
Citigroup
C
$222B
$12K 0.02%
278
+265
+2,038% +$11.1K
JLL icon
94
Jones Lang LaSalle
JLL
$16.3B
$12K 0.02%
+100
New +$12.1K
RTX icon
95
RTX Corp
RTX
$290B
$12K 0.02%
+188
New +$10.9K
VV icon
96
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
$12K 0.02%
129
+1
+0.8% +$89
SGEN
97
DELISTED
Seagen Inc. Common Stock
SGEN
$12K 0.02%
330
BMY icon
98
Bristol-Myers Squibb
BMY
$133B
$11K 0.02%
+167
New +$10.5K
CTSH icon
99
Cognizant
CTSH
$24.9B
$11K 0.02%
+176
New +$10.2K
CVS icon
100
CVS Health
CVS
$133B
$11K 0.02%
+108
New +$10.5K

Similar funds

Pathstone Family Office's Q1 2016 Portfolio in Review

As of Q1 2016, Pathstone Family Office held 195 positions worth $49.3M, up 130% from $21.5M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Pathstone Family Office deployed $1.13B of net new capital in Q1 2016, opening 101 new positions and adding to 30 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 5,600 shares worth $12M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 81% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $22.7K trimmed.

  • Pathstone Family Office's largest Q1 2016 buy was Berkshire Hathaway Class A: 5,600 shares worth $12M.
  • Pathstone Family Office added most to Gilead Sciences in Q1 2016, an estimated $5.46M increase.
  • Pathstone Family Office's biggest Q1 2016 reduction was Monsanto Co, cutting an estimated $22.7K.
  • Pathstone Family Office fully exited iShares Core US Aggregate Bond ETF in Q1 2016, selling an estimated $186K.
  • Pathstone Family Office's ten largest holdings make up 79% of its $49.3M portfolio in Q1 2016.
  • Pathstone Family Office opened 101 new positions and closed 16 in Q1 2016.
  • Pathstone Family Office's portfolio value rose 130% quarter-over-quarter to $49.3M.

Based on Pathstone Family Office's 13F filing for Q1 2016, filed 12 May 2016.